Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: CARCINOMA, HEPATOCELLULAR - PATHOLOGY , . Treffer: 50

2018

Li, M; Su, Y; Zhang, F; Chen, K; Xu, X; Xu, L; Zhou, J; Wang, W A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.
Acta Biomater. 2018; 75(10):413-426 Doi: 10.1016/j.actbio.2018.05.049
Web of Science PubMed FullText FullText_MUG

 

Qu, Z; Ling, Q; Gwiasda, J; Xu, X; Schrem, H; Beneke, J; Kaltenborn, A; Krauth, C; Mix, H; Klempnauer, J; Emmanouilidis, N Hangzhou criteria are more accurate than Milan criteria in predicting long-term survival after liver transplantation for HCC in Germany.
Langenbecks Arch Surg. 2018; 403(5): 643-654. Doi: 10.1007/s00423-018-1696-8
Web of Science PubMed FullText FullText_MUG

 

2017

Boege, Y; Malehmir, M; Healy, ME; Bettermann, K; Lorentzen, A; Vucur, M; Ahuja, AK; Böhm, F; Mertens, JC; Shimizu, Y; Frick, L; Remouchamps, C; Mutreja, K; Kähne, T; Sundaravinayagam, D; Wolf, MJ; Rehrauer, H; Koppe, C; Speicher, T; Padrissa-Altés, S; Maire, R; Schattenberg, JM; Jeong, JS; Liu, L; Zwirner, S; Boger, R; Hüser, N; Davis, RJ; Müllhaupt, B; Moch, H; Schulze-Bergkamen, H; Clavien, PA; Werner, S; Borsig, L; Luther, SA; Jost, PJ; Weinlich, R; Unger, K; Behrens, A; Hillert, L; Dillon, C; Di Virgilio, M; Wallach, D; Dejardin, E; Zender, L; Naumann, M; Walczak, H; Green, DR; Lopes, M; Lavrik, I; Luedde, T; Heikenwalder, M; Weber, A A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.
Cancer Cell. 2017; 32(3):342-359 Doi: 10.1016/j.ccell.2017.08.010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Cătană, CS; Pichler, M; Giannelli, G; Mader, RM; Berindan-Neagoe, I Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.
Oncotarget. 2017; 8(17):29519-29534 Doi: 10.18632/oncotarget.15706 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Dengler, M; Staufer, K; Huber, H; Stauber, R; Bantel, H; Weiss, KH; Starlinger, P; Pock, H; Klöters-Plachky, P; Gotthardt, DN; Rauch, P; Lackner, C; Stift, J; Brostjan, C; Gruenberger, T; Kumada, T; Toyoda, H; Tada, T; Weiss, TS; Trauner, M; Mikulits, W Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
Oncotarget. 2017; 8(28):46234-46248 Doi: 10.18632/oncotarget.17598 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ganten, TM; Stauber, RE; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Göhler, T; Walther, M; Koschny, R; Gerken, G Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study.
Clin Cancer Res. 2017; 23(19):5720-5728 Doi: 10.1158/1078-0432.CCR-16-0919 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gwiasda, J; Schulte, A; Kaltenborn, A; Ramackers, W; Kleine, M; Beetz, O; Klempnauer, J; Emmanouilidis, N; Schrem, H Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinoma.
Surg Oncol. 2017; 26(2): 178-187. Doi: 10.1016/j.suronc.2017.03.004
Web of Science PubMed FullText FullText_MUG

 

Lin, S; Hoffmann, K; Gao, C; Petrulionis, M; Herr, I; Schemmer, P Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma.
J PINEAL RES. 2017; 62(3): Doi: 10.1111/jpi.12398
Web of Science PubMed FullText FullText_MUG

 

Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
PLoS One. 2017; 12(11):e0187814-e0187814 Doi: 10.1371/journal.pone.0187814 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Hoyer, DP; Paul, A; Lauenstein, T; Bockisch, A; Treckmann, JW; Gerken, G; Mathé, Z [Relevance of Ablation Therapies for HCC: "A Real Bridging" for Liver Transplantation?].
Zentralbl Chir. 2016; 141(4):390-396 Doi: 10.1055/s-0032-1328569
Web of Science PubMed FullText FullText_MUG

 

Trierweiler, C; Hockenjos, B; Zatloukal, K; Thimme, R; Blum, HE; Wagner, EF; Hasselblatt, P The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.
Cell Death Differ. 2016; 23(4):576-582 Doi: 10.1038/cdd.2015.121 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Elgohary, N; Pellegrino, R; Neumann, O; Elzawahry, HM; Saber, MM; Zeeneldin, AA; Geffers, R; Ehemann, V; Schemmer, P; Schirmacher, P; Longerich, T Protumorigenic role of Timeless in hepatocellular carcinoma.
Int J Oncol. 2015; 46(2):597-606 Doi: 10.3892/ijo.2014.2751 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Flecken, T; Schmidt, N; Hild, S; Gostick, E; Drognitz, O; Zeiser, R; Schemmer, P; Bruns, H; Eiermann, T; Price, DA; Blum, HE; Neumann-Haefelin, C; Thimme, R Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.
Hepatology. 2014; 59(4):1415-1426 Doi: 10.1002/hep.26731 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoffmann, K; Müller-Bütow, V; Franz, C; Hinz, U; Longerich, T; Büchler, MW; Schemmer, P Factors predictive of survival after stapler hepatectomy of hepatocellular carcinoma: a multivariate, single-center analysis.
Anticancer Res. 2014; 34(2):767-776
Web of Science PubMed

 

Kessler, SM; Simon, Y; Gemperlein, K; Gianmoena, K; Cadenas, C; Zimmer, V; Pokorny, J; Barghash, A; Helms, V; van Rooijen, N; Bohle, RM; Lammert, F; Hengstler, JG; Mueller, R; Haybaeck, J; Kiemer, AK Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
Int J Mol Sci. 2014; 15(4):5762-5773 Doi: 10.3390/ijms15045762 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stampfl, U; Bermejo, JL; Sommer, CM; Hoffmann, K; Weiss, KH; Schirmacher, P; Schemmer, P; Kauczor, HU; Richter, GM; Radeleff, BA; Longerich, T Efficacy and nontarget effects of transarterial chemoembolization in bridging of hepatocellular carcinoma patients to liver transplantation: a histopathologic study.
J Vasc Interv Radiol. 2014; 25(7):1018-1026 Doi: 10.1016/j.jvir.2014.03.007
Web of Science PubMed FullText FullText_MUG

 

Thomann, S; Longerich, T; Bazhin, AV; Mier, W; Schemmer, P; Ryschich, E Selective targeting of liver cancer with the endothelial marker CD146.
Oncotarget. 2014; 5(18):8614-8624 Doi: 10.18632/oncotarget.2345 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Welte, S; Urbanik, T; Elßner, C; Kautz, N; Koehler, BC; Waldburger, N; Bermejo, JL; Pinna, F; Weiss, KH; Schemmer, P; Jaeger, D; Longerich, T; Breuhahn, K; Schulze-Bergkamen, H Nuclear expression of the deubiquitinase CYLD is associated with improved survival in human hepatocellular carcinoma.
PLoS One. 2014; 9(10):e110591-e110591 Doi: 10.1371/journal.pone.0110591 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Koschny, R; Brost, S; Hinz, U; Sykora, J; Batke, EM; Singer, S; Breuhahn, K; Stremmel, W; Walczak, H; Schemmer, P; Schirmacher, P; Ganten, TM Cytosolic and nuclear caspase-8 have opposite impact on survival after liver resection for hepatocellular carcinoma.
BMC Cancer. 2013; 13(5):532-532 Doi: 10.1186/1471-2407-13-532 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Aigelsreiter, A; Haybaeck, J; Schauer, S; Kiesslich, T; Bettermann, K; Griessbacher, A; Stojakovic, T; Bauernhofer, T; Samonigg, H; Kornprat, P; Lackner, C; Pichler, M NEMO expression in human hepatocellular carcinoma and its association with clinical outcome.
Hum Pathol. 2012; 43(7):1012-1019 Doi: 10.1016/j.humpath.2011.08.009
Web of Science PubMed FullText FullText_MUG

 

Leber, B; Mayrhauser, U; Leopold, B; Koestenbauer, S; Tscheliessnigg, K; Stadlbauer, V; Stiegler, P Impact of temperature on cell death in a cell-culture model of hepatocellular carcinoma.
Anticancer Res. 2012; 32(3):915-921
Web of Science PubMed

 

Peck-Radosavljevic, M; Stauber, RE; BCLC - now also an internationally acclaimed prognostic system?.
Liver Int. 2012; 32(7):1037-1038 Doi: 10.1111/j.1478-3231.2012.02840.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pinter, M; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Stauber, R; Grünberger, B; Müller, C; Kölblinger, C; Peck-Radosavljevic, M; Sieghart, W Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
Radiology. 2012; 263(2):590-599 Doi: 10.1148/radiol.12111550 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Sotiropoulos, GC; Tagkalos, E; Fouzas, I; Vernadakis, S; Mathé, Z; Treckmann, J; Paul, A Liver transplantation for hepatocellular carcinoma using extended criteria donor grafts.
Transplant Proc. 2012; 44(9):2730-2733 Doi: 10.1016/j.transproceed.2012.09.021
Web of Science PubMed FullText FullText_MUG

 

Zachau, L; Zeckey, C; Schlue, J; Sander, J; Meyer-Heithuis, C; Winkler, M; Klempnauer, J; Schrem, H Haematogenous abdominal wall metastasis of differentiated, alpha-fetoprotein-negative hepatocellular carcinoma after previous antiandrogen therapy within a site of lipoma manifestation since childhood.
World J Surg Oncol. 2012; 10(2): 98-98. Doi: 10.1186/1477-7819-10-98 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Hoffmann, K; Hinz, U; Hillebrand, N; Radeleff, BA; Ganten, TM; Schirmacher, P; Schmidt, J; Büchler, MW; Schemmer, P Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis.
Clin Transplant. 2011; 25(5):E541-E551 Doi: 10.1111/j.1399-0012.2011.01465.x
Web of Science PubMed FullText FullText_MUG

 

Hoffmann, K; Shibo, L; Xiao, Z; Longerich, T; Büchler, MW; Schemmer, P Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
Anticancer Res. 2011; 31(11):3883-3890
Web of Science PubMed

 

Lackner, C Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
Expert Rev Gastroenterol Hepatol. 2011; 5(2):223-231 Doi: 10.1586/egh.11.8
Web of Science PubMed FullText FullText_MUG

 

Mayrhauser, U; Stiegler, P; Stadlbauer, V; Koestenbauer, S; Leber, B; Konrad, K; Iberer, F; Portugaller, RH; Tscheliessnigg, K Effect of hyperthermia on liver cell lines: important findings for thermal therapy in hepatocellular carcinoma.
Anticancer Res. 2011; 31(5):1583-1588
Web of Science PubMed

 

Mayrhauser, U; Stiegler, P; Stadlbauer, V; Koestenbauer, S; Leber, B; Konrad, K; Iberer, F; Tscheliessnigg, K Cell to cell interactions influence sensitivity of liver cell lines during hyperthermia.
Anticancer Res. 2011; 31(11):3713-3717
Web of Science PubMed

 

O'Neill, DP; Peng, T; Stiegler, P; Mayrhauser, U; Koestenbauer, S; Tscheliessnigg, K; Payne, SJ A three-state mathematical model of hyperthermic cell death.
Ann Biomed Eng. 2011; 39(1):570-579 Doi: 10.1007/s10439-010-0177-1
Web of Science PubMed FullText FullText_MUG

 

2010

Denk, GU; Maitz, S; Wimmer, R; Rust, C; Invernizzi, P; Ferdinandusse, S; Kulik, W; Fuchsbichler, A; Fickert, P; Trauner, M; Hofmann, AF; Beuers, U Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Hepatology. 2010; 52(5): 1758-1768. Doi: 10.1002/hep.23911 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Hoffmann, K; Franz, C; Xiao, Z; Mohr, E; Serba, S; Büchler, MW; Schemmer, P Sorafenib modulates the gene expression of multi-drug resistance mediating ATP-binding cassette proteins in experimental hepatocellular carcinoma.
Anticancer Res. 2010; 30(11):4503-4508
Web of Science PubMed

 

Kahn, J; Kniepeiss, D; Langner, C; Wagner, D; Iberer, F; Tscheliessnigg, K Oesophageal metastases of hepatocellular carcinoma after liver transplantation.
Transpl Int. 2010; 23(4):438-439 Doi: 10.1111/j.1432-2277.2009.00967.x (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tomuleasa, C; Soritau, O; Rus-Ciuca, D; Pop, T; Todea, D; Mosteanu, O; Pintea, B; Foris, V; Susman, S; Kacsó, G; Irimie, A Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
J Gastrointestin Liver Dis. 2010; 19(1):61-67 [OPEN ACCESS]
Web of Science PubMed

 

Vernadakis, S; Poetsch, M; Weber, F; Treckmann, J; Mathe, Z; Baba, HA; Paul, A; Kaiser, GM Donor origin de novo HCC in a noncirrhotic liver allograft 3 years after liver transplantation.
Transpl Int. 2010; 23(3):341-343 Doi: 10.1111/j.1432-2277.2009.00942.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2009

Aigelsreiter, A; Janig, E; Sostaric, J; Pichler, M; Unterthor, D; Halasz, J; Lackner, C; Zatloukal, K; Denk, H Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
Histopathology. 2009; 54(5): 561-570. Doi: 10.1111/j.1365-2559.2009.03258.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Grabarević, Z; Corić, M; Seiwerth, S; Dzaja, P; Artuković, B; Kurilj, AG; Beck, A; Hohsteter, M; Sostarić-Zuckermann, IC; Brcić, L; Hrstić, I Comparative analysis of hepatocellular carcinoma in men and dogs.
Coll Antropol. 2009; 33(3): 811-814.
Web of Science PubMed

 

Kashofer, K; Tschernatsch, MM; Mischinger, HJ; Iberer, F; Zatloukal, K The disease relevance of human hepatocellular xenograft models: molecular characterization and review of the literature.
Cancer Lett. 2009; 286(1):121-128 Doi: 10.1016/j.canlet.2008.11.011
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Salnikov, AV; Kusumawidjaja, G; Rausch, V; Bruns, H; Gross, W; Khamidjanov, A; Ryschich, E; Gebhard, MM; Moldenhauer, G; Büchler, MW; Schemmer, P; Herr, I Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
Cancer Lett. 2009; 275(2):185-193 Doi: 10.1016/j.canlet.2008.10.015
Web of Science PubMed FullText FullText_MUG

 

2007

Herr, I; Groth, A; Schemmer, P; Büchler, MW Adult stem cells in progression and therapy of hepatocellular carcinoma.
Int J Cancer. 2007; 121(9):1875-1882 Doi: 10.1002/ijc.23041
Web of Science PubMed FullText FullText_MUG

 

Herr, I; Schemmer, P; Büchler, MW On the TRAIL to therapeutic intervention in liver disease.
Hepatology. 2007; 46(1):266-274 Doi: 10.1002/hep.21740
Web of Science PubMed FullText FullText_MUG

 

2005

Zollner, G; Wagner, M; Fickert, P; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Hepatobiliary transporter expression in human hepatocellular carcinoma.
Liver Int. 2005; 25(2):367-379 Doi: 10.1111/j.1478-3231.2005.01033.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Schachtrup, C; Emmler, T; Bleck, B; Sandqvist, A; Spener, F Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins.
Biochem J. 2004; 382(Pt 1):239-245 Doi: 10.1042/BJ20031340 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Zacherl, J; Scheuba, C; Imhof, M; Zacherl, M; Längle, F; Pokieser, P; Wrba, F; Wenzl, E; Mühlbacher, F; Jakesz, R; Steininger, R Current value of intraoperative sonography during surgery for hepatic neoplasms.
World J Surg. 2002; 26(5):550-554 Doi: 10.1007/s00268-001-0266-2
Web of Science PubMed FullText FullText_MUG

 

1999

Stumptner, C; Heid, H; Fuchsbichler, A; Hauser, H; Mischinger, HJ; Zatloukal, K; Denk, H Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.
Am J Pathol. 1999; 154(6):1701-1710 Doi: 10.1016/S0002-9440(10)65426-0 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

Kubicka, S; Trautwein, C; Schrem, H; Tillmann, H; Manns, M Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event.
J Hepatol. 1995; 23(4):412-419 Doi: 10.1016/0168-8278(95)80199-5
Web of Science PubMed FullText FullText_MUG

 

1993

Stauber, RE; Mischinger, HJ; Trauner, M; Pristautz, H Indications for liver transplantation in neoplasms of the liver.
Acta Med Austriaca. 1993; 20(3):57-60
Web of Science PubMed Google Scholar

 

1987

Klimpfinger, M; Jatzko, G; Trink, A; Samec, HJ; Gaugg, A 76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type
Wien Klin Wochenschr. 1987; 99(14):505-509 (- Case Report)
Web of Science PubMed

 

1980

Popper, H Bidermal hepatoblastoma in an adult (author's transl)
Zentralbl Allg Pathol. 1980; 124(5): 403-409. (- Case Report)
PubMed

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum